Description:BMS-299897, with the CAS number 290315-45-6, is a chemical compound that has been studied primarily for its potential therapeutic applications, particularly in the field of neuroscience. It is known to act as a selective antagonist of the dopamine D3 receptor, which is implicated in various neuropsychiatric disorders. The compound's structure features a distinct arrangement of functional groups that contribute to its biological activity and receptor selectivity. BMS-299897 has been evaluated in preclinical studies for its effects on behaviors related to addiction and mood disorders, showcasing its potential as a candidate for drug development. Additionally, its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are crucial for understanding its efficacy and safety profile. Overall, BMS-299897 represents a significant interest in medicinal chemistry, particularly in the context of developing new treatments for conditions associated with dopamine dysregulation.
Please enquire for more information about 2-[(1R)-1-[[(4-Chlorophenyl)sulfonyl](2,5-difluorophenyl)amino]ethyl]-5-fluorobenzenebutanoic acid including the price, delivery time and more …
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.